FDA Clears Haegarda to Prevent Hereditary Angiodema Attacks FDA Clears Haegarda to Prevent Hereditary Angiodema Attacks

Haegarda is the first C1 esterase inhibitor (human) for at-home subcutaneous administration for the prevention of hereditary angioedema attacks in adolescents and adults.FDA Approvals (Source: Medscape Medical News Headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2tXHiML
via IFTTT